Intermittent short course enzalutamide in biochemically recurrent prostate cancer: Analysis of PSA recovery, testosterone levels and tolerability
| Autor: | William D. Figg, J. Schlom, Inger L. Rosner, Jennifer L. Marte, Marijo Bilusic, Anna Couvillon, James L. Gulley, Helen Owens, Ravi A. Madan, Philip M. Arlen, Lisa M. Cordes, M. Al Harthy, Marc R. Theoret, W. L. Dahut, Amy Hankin, Julius Strauss, Fatima Karzai, Harpreet Singh |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry 030232 urology & nephrology Testosterone (patch) Hematology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Tolerability 030220 oncology & carcinogenesis Internal medicine medicine Enzalutamide Recurrent prostate cancer Short course business |
| Zdroj: | Annals of Oncology. 29:viii297 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdy284.059 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|